Skip to main content
Figure 1 | Molecular Cancer

Figure 1

From: Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers

Figure 1

MSeA effect on intracellular expression of β-catenin. Six human cancer cell lines including 2 colorectal (HT-29 and HCT-8), 2 head and neck (FaDu and A253) and 2 prostate (PC3 and C42) were treated with various doses of MSeA (panel 1A) and various times (panel 1B). Western blot analyses show that MSeA inhibits intracellular level of β-catenin in dose and time dependent manners.

Back to article page